11 – 20 of 89
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma
(
- Contribution to journal › Article
- 2019
-
Mark
Engineered human mesenchymal stem cells for neuroblastoma therapeutics
(
- Contribution to journal › Article
-
Mark
Multidimensional intratumour heterogeneity in neuroblastoma
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Hypoxia and Stem Cells in Normal and Tumor Development
(
- Thesis › Doctoral thesis (compilation)
- 2018
-
Mark
Promoter-associated proteins of EPAS1 identified by enChIP-MS – A putative role of HDX as a negative regulator
(
- Contribution to journal › Article
-
Mark
Hypoxia and hypoxia-inducible factors in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Haploidentical Stem Cell Transplantation for Refractory/Relapsed Neuroblastoma
(
- Contribution to journal › Article
-
Mark
Sense-Antisense lncRNA Pair Encoded by Locus 6p22.3 Determines Neuroblastoma Susceptibility via the USP36-CHD7-SOX9 Regulatory Axis
(
- Contribution to journal › Article
-
Mark
Patient-derived xenografts as preclinical neuroblastoma models
(
- Contribution to journal › Article